Trial intelligence / Profile preview

Spirulina vs Amlodipine for Cardiac Iron Overload in Beta Thalassemia

NCT02671695Completed

Sponsor
Tanta University
Start
Apr 2015
Primary completion
Apr 2018
Modality
Dietary Supplement
Countries
1
01

Overview

Randomised trial of spirulina in beta thalassemia major, sponsored by Tanta University. Primary endpoint: Cardiac iron concentration by magnetic resonance imaging at 3 months. Started Apr 2015; status: completed.

02

Drugs

spirulina
03

Conditions

beta thalassemia major

Beyond the preview

Go deeper on NCT02671695.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02671695.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call